All In Biotech

Drug Trial Radar · NCT00226096

Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage

A Randomised Trial to Establish the Effects of Early Intensive Blood Pressure Lowering on Death and Disability in Patients With Stroke Due to Acute Intracerebral Haemorrhage

Last checked: Nov 19, 2026Latest source record: Jun 26, 2008 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 404 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

404

Actual

Start

Nov 2005

Primary completion

Sep 2007

Study completion Sep 2007

Sponsor

Lead sponsor
The George InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Health and Medical Research Council, Australia
First posted
Sep 26, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to determine whether lowering high blood pressure levels after the start of a stroke caused by bleeding in the brain (intracerebral haemorrhage) will reduce the chances of a person dying or surviving with a long term disability. The study will be undertaken in two phases: a vanguard phase in 400 patients, to plan for a main phase in 2000 patients.

Conditions

  • CVA (Cerebrovascular Accident)
  • Cerebral Hemorrhage
  • Intracranial Hemorrhages

Interventions

  • Labetalol HydrochlorideDrug

  • Metoprolol tartrateDrug

  • Hydralazine HydrochlorideDrug

  • Glycerol TrinitrateDrug

  • Phentolamine mesylateDrug

  • NicardipineDrug

  • UrapidilDrug

  • EsmololDrug

  • ClonidineDrug

  • EnalaprilatDrug

  • NitroprussideDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Combination death and dependency, according to a 3-6 scores on the modified Rankin Score.Time frame: 3 months

Locations

20 sites in 3 countries. Site status is shown where the registry gives one.

  • Concord Hospital

    Concord, New South Wales, Australia

  • Gosford Hospital

    Gosford, New South Wales, Australia

  • St George Hospital

    Kogarah, New South Wales, Australia

  • John Hunter Hospital

    Newcastle, New South Wales, Australia

  • St Vincent's Hospital

    Sydney, New South Wales, Australia

  • Royal Prince Alfred Hospital

    Sydney, New South Wales, Australia

  • Westmead Hospital

    Westmead, New South Wales, Australia

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia

  • Royal Melbourne Hospital

    Melbourne, Victoria, Australia

  • St Vincent's Hospital

    Melbourne, Victoria, Australia

  • Box Hill Hospital

    Melbourne, Victoria, Australia

  • Alfred Hospital

    Melbourne, Victoria, Australia

  • Austin Health

    Melbourne, Victoria, Australia

  • Monash Medical Centre

    Melbourne, Victoria, Australia

  • Sir Charles Gairdner Hospital

    Perth, Western Australia, Australia

  • Regional Coordinating Centre: Peking University First Hospital

    Beijing, China

  • Hospitals in China, c/o The George Institute China

    Beijing, China

  • Regional Coordinating Centre: Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, Shanghai Second Medical University

    Shanghai, China

  • North Shore Hospital

    Auckland, New Zealand

  • Christchurch Hospital

    Christchurch, New Zealand

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.